Discovery of Highly Potent BET Inhibitors based on a Tractable Tricyclic ScaffoldACS MEDICINAL CHEMISTRY LETTERSIF42025-03-010OAAI
Design and Characterization of 1,3-Dihydro-2H-benzo[d]azepin-2-ones as Rule-of-5 Compliant Bivalent BET InhibitorsACS MEDICINAL CHEMISTRY LETTERSIF42023-08-142PRE
Multigram Synthesis of Tetrasubstituted Dihydrobenzofuran GSK973 Enabled by High-Throughput Experimentation and a Claisen Rearrangement in Flow (vol 26, pg 365, 2022)ORGANIC PROCESS RESEARCH & DEVELOPMENTIF3.52022-03-100PRE
Multigram Synthesis of Tetrasubsituted Dihydrobenzofuran GSK973 Enabled by High-Throughput Experimentation and a Claisen Rearrangement in FlowORGANIC PROCESS RESEARCH & DEVELOPMENTIF3.52022-01-244PRE
Design, Synthesis, and Characterization of I-BET567, a Pan-Bromodomain and Extra Terminal (BET) Bromodomain Oral CandidateJOURNAL OF MEDICINAL CHEMISTRYIF6.82022-01-0719OA
Optimization of a Series of 2,3-Dihydrobenzofurans as Highly Potent, Second Bromodomain (BD2)-Selective, Bromo and Extra-Terminal Domain (BET) InhibitorsJOURNAL OF MEDICINAL CHEMISTRYIF6.82021-07-1417OA
Fragment-based Scaffold Hopping: Identification of Potent, Selective, and Highly Soluble Bromo and Extra Terminal Domain (BET) Second Bromodomain (BD2) InhibitorsJOURNAL OF MEDICINAL CHEMISTRYIF6.82021-07-1317PRE
Discovery of a Highly Selective BET BD2 Inhibitor from a DNA-Encoded Library Technology Screening HitJOURNAL OF MEDICINAL CHEMISTRYIF6.82021-07-1230PREAI
Identification of a Series of N-Methylpyridine-2-carboxamides as Potent and Selective Inhibitors of the Second Bromodomain (BD2) of the Bromo and Extra Terminal Domain (BET) ProteinsJOURNAL OF MEDICINAL CHEMISTRYIF6.82021-07-0716PREAI
Template-Hopping Approach Leads to Potent, Selective, and Highly Soluble Bromo and Extraterminal Domain (BET) Second Bromodomain (BD2) InhibitorsJOURNAL OF MEDICINAL CHEMISTRYIF6.82021-03-0419PREAI
The Optimization of a Novel, Weak Bromo and Extra Terminal Domain (BET) Bromodomain Fragment Ligand to a Potent and Selective Second Bromodomain (BD2) InhibitorJOURNAL OF MEDICINAL CHEMISTRYIF6.82020-07-2344OAAI
Design and Synthesis of a Highly Selective and In Vivo-Capable Inhibitor of the Second Bromodomain of the Bromodomain and Extra Terminal Domain Family of ProteinsJOURNAL OF MEDICINAL CHEMISTRYIF6.82020-07-2138OAAI
GSK973 Is an Inhibitor of the Second Bromodomains (BD2s) of the Bromodomain and Extra-Terminal (BET) FamilyACS MEDICINAL CHEMISTRY LETTERSIF42020-07-0625OAAI
Selective targeting of BD1 and BD2 of the BET proteins in cancer and immunoinflammationScienceIF45.82020-01-010OAAI
Cell Penetrant Inhibitors of the KDM4 and KDM5 Families of Histone Lysine Demethylases. 2. Pyrido[3,4-d]pyrimidin-4(3H)-one DerivativesJOURNAL OF MEDICINAL CHEMISTRYIF6.82016-01-1564PREAI
Cell Penetrant Inhibitors of the KDM4 and KDM5 Families of Histone Lysine Demethylases. 1. 3-Amino-4-pyridine Carboxylate DerivativesJOURNAL OF MEDICINAL CHEMISTRYIF6.82016-01-1549PREAI
个人简介
教育背景
工作经历
荣誉奖项
未登录.png){kind=icon}
未登录个人简介教育背景工作经历荣誉奖项
研究方向